IPP Bureau
DS-7300 Phase 2 Trial Initiated in Patients with Pretreated ExtensiveStage Small Cell Lung Cancer
By IPP Bureau - July 21, 2022
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Syngene reports revenue from operations up 8% in Q1 FY 23
By IPP Bureau - July 21, 2022
Company raises the annual revenue guidance from mid-teens to high teens
India’s first 4th Gen transcatheter mitral valve performed at Apollo Chennai
By IPP Bureau - July 21, 2022
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round
By IPP Bureau - July 20, 2022
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease
By IPP Bureau - July 20, 2022
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
Roche launches Elecsys HCV Duo immunoassay for hepatitis C virus
By IPP Bureau - July 20, 2022
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
Essential Pharma progress in its ESG performance
By IPP Bureau - July 20, 2022
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy
By IPP Bureau - July 20, 2022
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
GSK’s Haleon begins trading in LSE
By IPP Bureau - July 20, 2022
Completion of the demerger of Haleon and share consolidation of GSK
Lupin Diagnostics launches its first reference laboratory in Ranchi
By IPP Bureau - July 19, 2022
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
Pharma manufacturer 'Gansons' turns 75
By IPP Bureau - July 18, 2022
Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.
India crosses ‘200 Crore’ COVID-19 vaccinations
By IPP Bureau - July 18, 2022
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune
By IPP Bureau - July 18, 2022
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
Orchid Pharma updates on PLI scheme benefits for its subsidiary
By IPP Bureau - July 18, 2022
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
